Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents

@article{Botchway2022AlzheimerDR,
  title={Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents},
  author={Benson O. A. Botchway and Favour C. Okoye and Yili Chen and William Erzuah Arthur and Maro Fang},
  journal={Aging and Disease},
  year={2022},
  volume={13},
  pages={87 - 102}
}
Alzheimer’s disease (AD) is a current public health challenge and will remain until the development of an effective intervention. However, developing an effective treatment for the disease requires a thorough understanding of its etiology, which is currently lacking. Although several studies have shown the association between oxidative damage and AD, only a few have clarified the specific mechanisms involved. Herein, we reviewed recent preclinical and clinical studies that indicated the… 

Figures and Tables from this paper

The Potential Role of Polyphenols in Oxidative Stress and Inflammation Induced by Gut Microbiota in Alzheimer’s Disease

TLDR
The role of oxidative stress, inflammation, and GM in AD is summarized and the ability of polyphenols to modulate gut dysbiosis, oxidative Stress, and inflammation against AD is provided.

Nutrient-Response Pathways in Healthspan and Lifespan Regulation

TLDR
Recently uncovered knowledge around nutrient-response pathways, such as the Insulin Growth Factor (IGF) and the mechanistic Target of Rapamycin signaling pathways, are examined, as well as specific GWAS and some EWAS studies on lifespan and age-related disease that have enhanced current understanding within the aging and biogerontology fields.

A Systematic Review of Body Fluids Biomarkers Associated With Early Neurological Deterioration Following Acute Ischemic Stroke

TLDR
Using a single body fluids biomarker may not accurately predict the risk of stroke progression, and it is necessary to combine multiple biomarkers (panels, scores, or indices) to improve their capacity to estimate END.

References

SHOWING 1-10 OF 150 REFERENCES

Positive association of a Sirt1 variant and parameters of oxidative stress on Alzheimer’s disease

TLDR
The hypothesis that AD is a condition with increased oxidative stress and genomic instability, which may contribute to the neurodegeneration in AD is supported.

Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?

TLDR
Whether and how GM dysbiosis could contribute to AD development through action on the immune system and whether, in a therapeutic prospective, the development of strategies preserving a healthy GM might become a valuable approach to prevent AD is reviewed.

Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease

TLDR
The role of oxidative stress in synaptic dysfunction in AD, innovative therapeutic strategies evolved based on a better understanding of the complexity of molecular mechanisms of AD, and the dual role ROS play in health and disease are discussed.

Oxidative stress as a biomarker for Alzheimer's disease.

TLDR
Loosely bound metal ions (copper and iron), present in the brain and at high concentration in senile plaques of AD patients, may bind to the amyloid beta peptide (Aβ), thus catalyzing very efficiently the production of ROS (in particular, the oligomeric forms of Aβ, known as being the most toxic).

Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2

TLDR
This study provides the first report attesting that patients with ND have high NOX2 activation that could be potentially implicated in the process of neuroinflammation.

Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.

TLDR
Modulating the gut microbiome and amyloidogenesis through specific nutritional interventions might prove to be an effective strategy to prevent or reduce the risk of Alzheimer disease.

Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression

TLDR
GV-971, a sodium oligomannate that has demonstrated solid and consistent cognition improvement in a phase 3 clinical trial in China, suppresses gut dysbiosis and the associated phenylalanine/isoleucine accumulation, harnesses neuroinflammation and reverses the cognition impairment.

Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment

TLDR
In confirming the occurrence of oxidative stress in AD and MCI patients, this study shows how it can be related, at least for superoxide dismutase activity in MCI, to APO E4 allele risk factor.
...